ATE321770T1 - Pseudoerythromycin-derivate - Google Patents
Pseudoerythromycin-derivateInfo
- Publication number
- ATE321770T1 ATE321770T1 AT00953461T AT00953461T ATE321770T1 AT E321770 T1 ATE321770 T1 AT E321770T1 AT 00953461 T AT00953461 T AT 00953461T AT 00953461 T AT00953461 T AT 00953461T AT E321770 T1 ATE321770 T1 AT E321770T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- pseudoerythromycin
- psedoerythromycin
- sulfonyl
- alkynyl
- Prior art date
Links
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00953461A EP1256587B1 (de) | 2000-08-17 | 2000-08-17 | Pseudoerythromycin-derivate |
| PCT/JP2000/005503 WO2002014338A1 (en) | 2000-08-17 | 2000-08-17 | Novel pseudoerythromycin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE321770T1 true ATE321770T1 (de) | 2006-04-15 |
Family
ID=11736361
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04022619T ATE316977T1 (de) | 2000-08-17 | 2000-08-17 | Neue pseudoerythromycin derivate |
| AT00953461T ATE321770T1 (de) | 2000-08-17 | 2000-08-17 | Pseudoerythromycin-derivate |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04022619T ATE316977T1 (de) | 2000-08-17 | 2000-08-17 | Neue pseudoerythromycin derivate |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6734292B1 (de) |
| EP (2) | EP1489090B1 (de) |
| KR (6) | KR20040066187A (de) |
| AT (2) | ATE316977T1 (de) |
| AU (1) | AU2000265939A1 (de) |
| CA (1) | CA2386828C (de) |
| DE (2) | DE60027015T2 (de) |
| DK (1) | DK1489090T3 (de) |
| ES (2) | ES2261224T3 (de) |
| PT (1) | PT1489090E (de) |
| WO (1) | WO2002014338A1 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| JP2002534468A (ja) | 1999-01-13 | 2002-10-15 | バイエル コーポレイション | ｐ３８キナーゼ阻害剤としてのω−カルボキシアリール置換ジフェニル尿素 |
| US7351834B1 (en) | 1999-01-13 | 2008-04-01 | Bayer Pharmaceuticals Corporation | ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| EP2324825A1 (de) | 2002-02-11 | 2011-05-25 | Bayer Healthcare LLC | Arylharnstoffe mit Angiogenese hemmender Aktivität |
| US20030216396A1 (en) | 2002-02-11 | 2003-11-20 | Bayer Corporation | Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors |
| US20040067896A1 (en) * | 2002-07-25 | 2004-04-08 | The Kitasato Institute | Novel pseudoerythromycin derivatives |
| UY28213A1 (es) | 2003-02-28 | 2004-09-30 | Bayer Pharmaceuticals Corp | Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos. |
| JP4860474B2 (ja) | 2003-05-20 | 2012-01-25 | バイエル、ファーマシューテイカルズ、コーポレイション | Ｐｄｇｆｒによって仲介される病気のためのジアリール尿素 |
| JP4777887B2 (ja) | 2003-07-23 | 2011-09-21 | バイエル、ファーマシューテイカルズ、コーポレイション | 病気および状態の処置および防止のためのフロロ置換オメガカルボキシアリールジフェニル尿素 |
| JP2008522978A (ja) * | 2004-12-07 | 2008-07-03 | エナンタ ファーマシューティカルズ インコーポレイテッド | ３，６−ビシクロライド |
| US7229972B2 (en) * | 2004-12-07 | 2007-06-12 | Enanta Pharmaceuticals, Inc. | 3,6-Bicyclolides |
| JP2009506066A (ja) | 2005-08-24 | 2009-02-12 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| EA015737B1 (ru) | 2005-10-14 | 2011-10-31 | Дзе Китасато Инститьют | Новые производные дигидропсевдоэритромицина |
| US7407942B2 (en) * | 2006-03-29 | 2008-08-05 | Emata Pharmaceuticals, Inc | 3,6-bridged 9,12-oxolides |
| US8080645B2 (en) * | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
| US8652782B2 (en) | 2006-09-12 | 2014-02-18 | Longhorn Vaccines & Diagnostics, Llc | Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids |
| US8097419B2 (en) | 2006-09-12 | 2012-01-17 | Longhorn Vaccines & Diagnostics Llc | Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009 |
| US9481912B2 (en) | 2006-09-12 | 2016-11-01 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
| US20090098527A1 (en) * | 2006-09-12 | 2009-04-16 | Fischer Gerald W | Biological organism identification product and methods |
| US11041215B2 (en) | 2007-08-24 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | PCR ready compositions and methods for detecting and identifying nucleic acid sequences |
| US9683256B2 (en) | 2007-10-01 | 2017-06-20 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system |
| AU2008293504B2 (en) | 2007-08-27 | 2012-04-12 | Longhorn Vaccines & Diagnostics, Llc | Immunogenic compositions and methods |
| US10004799B2 (en) | 2007-08-27 | 2018-06-26 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
| US11041216B2 (en) | 2007-10-01 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples |
| CA2701168A1 (en) | 2007-10-01 | 2009-07-09 | Longhorn Vaccines & Diagnostics, Llc | Biological specimen collection and transport system and methods of use |
| JP5733601B2 (ja) * | 2010-07-13 | 2015-06-10 | 国立大学法人 千葉大学 | 劇症型炎症の予防および／または治療剤 |
| EP2806890A4 (de) | 2012-01-26 | 2015-09-02 | Longhorn Vaccines & Diagnostics Llc | Zusammengesetzte antigensequenzen und impfstoffe |
| EP3294448A4 (de) | 2015-05-14 | 2018-12-12 | Longhorn Vaccines and Diagnostics, LLC | Schnellverfahren zur extraktion von nukleinsäuren aus biologischen proben |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5106961A (en) | 1987-05-26 | 1992-04-21 | Eli Lilly And Company | Erythromycin ring-contracted derivatives |
| CA1321581C (en) | 1987-05-26 | 1993-08-24 | Herbert A. Kirst | Ring-contracted macrolides |
| US4920102A (en) * | 1988-04-18 | 1990-04-24 | Eli Lilly And Company | Method for treating gastrointestinal disorders |
| KR100222014B1 (ko) * | 1991-04-09 | 1999-10-01 | 스티븐 에프. 웨인스톡 | 거대환식 락탐 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물 |
| US5523401A (en) | 1991-04-09 | 1996-06-04 | Abbott Laboratories | Macrocyclic lactam prokinetic agents |
| DE4200145A1 (de) * | 1992-01-07 | 1993-07-08 | Kali Chemie Pharma Gmbh | 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE19644195A1 (de) * | 1996-10-24 | 1998-04-30 | Solvay Pharm Gmbh | 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE19805822B4 (de) | 1998-02-13 | 2009-02-05 | Solvay Pharmaceuticals Gmbh | 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
-
2000
- 2000-08-17 AT AT04022619T patent/ATE316977T1/de not_active IP Right Cessation
- 2000-08-17 EP EP04022619A patent/EP1489090B1/de not_active Expired - Lifetime
- 2000-08-17 DK DK04022619T patent/DK1489090T3/da active
- 2000-08-17 AU AU2000265939A patent/AU2000265939A1/en not_active Abandoned
- 2000-08-17 KR KR10-2004-7009828A patent/KR20040066187A/ko not_active Application Discontinuation
- 2000-08-17 EP EP00953461A patent/EP1256587B1/de not_active Expired - Lifetime
- 2000-08-17 KR KR10-2004-7009825A patent/KR20040066184A/ko not_active Application Discontinuation
- 2000-08-17 WO PCT/JP2000/005503 patent/WO2002014338A1/ja active IP Right Grant
- 2000-08-17 DE DE60027015T patent/DE60027015T2/de not_active Expired - Fee Related
- 2000-08-17 KR KR10-2004-7009827A patent/KR20040066186A/ko not_active Application Discontinuation
- 2000-08-17 ES ES00953461T patent/ES2261224T3/es not_active Expired - Lifetime
- 2000-08-17 AT AT00953461T patent/ATE321770T1/de not_active IP Right Cessation
- 2000-08-17 KR KR10-2004-7009829A patent/KR20040066188A/ko not_active Application Discontinuation
- 2000-08-17 KR KR10-2004-7009826A patent/KR20040066185A/ko not_active Application Discontinuation
- 2000-08-17 US US10/088,965 patent/US6734292B1/en not_active Expired - Fee Related
- 2000-08-17 PT PT04022619T patent/PT1489090E/pt unknown
- 2000-08-17 CA CA002386828A patent/CA2386828C/en not_active Expired - Fee Related
- 2000-08-17 KR KR10-2004-7009830A patent/KR20040074096A/ko not_active Application Discontinuation
- 2000-08-17 ES ES04022619T patent/ES2257720T3/es not_active Expired - Lifetime
- 2000-08-17 DE DE60025856T patent/DE60025856T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040066186A (ko) | 2004-07-23 |
| KR20040066184A (ko) | 2004-07-23 |
| ATE316977T1 (de) | 2006-02-15 |
| DK1489090T3 (da) | 2006-05-22 |
| KR20040066187A (ko) | 2004-07-23 |
| EP1489090B1 (de) | 2006-02-01 |
| PT1489090E (pt) | 2006-05-31 |
| EP1256587A4 (de) | 2004-01-28 |
| ES2257720T3 (es) | 2006-08-01 |
| DE60027015T2 (de) | 2006-10-05 |
| KR20040074096A (ko) | 2004-08-21 |
| DE60025856D1 (de) | 2006-04-13 |
| US6734292B1 (en) | 2004-05-11 |
| WO2002014338A1 (en) | 2002-02-21 |
| EP1489090A1 (de) | 2004-12-22 |
| KR20040066185A (ko) | 2004-07-23 |
| EP1256587A1 (de) | 2002-11-13 |
| DE60027015D1 (en) | 2006-05-18 |
| AU2000265939A1 (en) | 2002-02-25 |
| EP1256587B1 (de) | 2006-03-29 |
| KR20040066188A (ko) | 2004-07-23 |
| CA2386828C (en) | 2006-01-24 |
| CA2386828A1 (en) | 2002-02-21 |
| ES2261224T3 (es) | 2006-11-16 |
| DE60025856T2 (de) | 2006-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE321770T1 (de) | Pseudoerythromycin-derivate | |
| DK2314582T3 (da) | Heterocykliske forbindelser som antivirusmidler | |
| ECSP045294A (es) | Derivados de 2,4-diaminopirimidina | |
| ECSP056195A (es) | Derivados de n-alquinil-2(ariloxi-sustituido)alquiltioamida como fungicidas | |
| UY26551A1 (es) | " agentes antibacterianos de 3-aminoquinazolin-2,4,dionas". | |
| HRP20080664A2 (en) | Substituted pyridine herbicides | |
| DE69728761D1 (de) | Heterocyclisch substituierte benzolderivate und herbizide | |
| EA200400893A1 (ru) | N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств | |
| DK1131315T3 (da) | Polyhydroxylerede heterocykliske derivater som antikoagulanter | |
| CY1111816T1 (el) | Παραγωγο θειαδιαζολινης για την θεραπεια του καρκινου | |
| HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
| ATE278661T1 (de) | Anthranilsäurederivate | |
| MA27046A1 (fr) | Nouveaux derives d'oxazolidinones en tant qu'agents antibacteriens. | |
| PT992509E (pt) | Novos derivados macrolidos | |
| BRPI0408675A (pt) | derivados de talidomida solúveis em água | |
| EA200400822A1 (ru) | Производные 3,4-дигидро-1h-изохинолин-2-ила | |
| DE60017374D1 (de) | Antibakterielle mittel | |
| DK1338596T3 (da) | Fremgangsmåde til fremstilling af antibakterielt middel af carbapenemtypen | |
| EA200200838A1 (ru) | N-(гетероциклил)бензол- или пиридинсульфонамиды в качестве антитромботических агентов и антикоагулянтов | |
| ES2159489A1 (es) | Nuevos derivados de imidazol con actividad antiinflamatoria. | |
| BR0113978A (pt) | Derivados de tiazol de 2-metoxiimino-2-(piridiniloximetil)-fenil-acetamidas úteis como fungicidas | |
| AR024797A1 (es) | Forma cristalina iii de la n-(4-(5-dimetilaminonaftalen-1-sulfonilamino)fenil)-3-hidroxi-2,2-dimetilpropionamida | |
| BR0210749A (pt) | Composições de fragrância e sabor | |
| BR0110328A (pt) | Compostos heterocìclicos com atividade antiinflamatória | |
| DE60211686D1 (de) | Pkb-3564-substanz mit die gefässneubildung hemmender wirkung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1256587 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |